Table 2.
PVE (n = 298) | No PVE (n = 1186) | p-Value | |
---|---|---|---|
Pathology diagnosis (n = 1460) | 0.830 | ||
Perihilar cholangiocarcinoma | 279 (95) | 1088 (93) | |
Benign | 6 (2) | 29 (3) | |
Other | 8 (3) | 48 (4) | |
Tumor-free margin (n = 1417) | 185 (64) | 745 (66) | 0.341 |
Morbidity Dindo grade III or higher (n = 1474) | 177 (59) | 520 (44) | < 0.001 |
Liver failure ISGLS grade B/C (n = 1472) | 81 (27) | 166 (14) | < 0.001 |
Biliary leakage ISGLS grade B/C (n = 1475) | 59 (20) | 248 (21) | 0.690 |
Hemorrhage ISGLS grade B/C (n = 1214) | 18 (10) | 61 (6) | 0.078 |
Intra-abdominal abscess (n = 1475) | 50 (17) | 257 (22) | 0.127 |
90-day mortality (n = 1484) | 53 (18) | 136 (12) | 0.005 |
Data are expressed as n (%)
PVE Portal vein embolization, ISGLS International Study Group of Liver Surgery